logo

For the Inventor, By the Inventor

Taipei, Taiwan

Chiu-Chen Huang

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 128(Granted Patents)


Company Filing History:

goldMedal7 out of 12 
 
Abgenomics Cooperatief U.a.
 patents
silverMedal4 out of 10 
 
Bioalliance C.v.
 patents
bronzeMedal4 out of 5 
 
Abgenomics International Inc.
 patents
4. 1 out of 8 
 
Cho Pharma Inc.
 patents
where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 10538592 - Antibodies, binding fragments, and methods of use (2020-01-21),
2. 10030075 - Methods of treating with anti-PSGL-1 antibodies (2018-07-24),
3. 9950077 - Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof (2018-04-24),
4. 9943610 - Hydrophilic self-immolative linkers and conjugates thereof (2018-04-17),
5. 9631019 - Methods of treating GVHD and transplant rejection with anti-PSGL-1 antibodies (2017-04-25),
6. 9408923 - Hydrophilic self-immolative linkers and conjugates thereof (2016-08-09),
7. 9089614 - Hydrophilic self-immolative linkers and conjugates thereof (2015-07-28),
8. 8828397 - Anti-PSGL-1 antibodies and methods of inducing cell death of an activated T cell (2014-09-09),
9. 8663641 - Anti-PSGL-1 antibodies (2014-03-04),
10. 8361472 - Anti-PSGL-1 antibodies (2013-01-29),
11. 8287871 - Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodies (2012-10-16),
12. 7604800 - Anti-PSGL-1 antibodies (2009-10-20),

Sure, I'd be happy to help with that article! Here it is:

Title: Unveiling the Innovations of Chiu-Chen Huang: A Pioneer in Cancer Research

Introduction: Chiu-Chen Huang, a proficient inventor based in Taipei, Taiwan, has left an indelible mark in the realm of medical innovations with his groundbreaking patents and research contributions.

Latest Patents: Among his remarkable patents is the invention of "Antibodies, binding fragments, and methods of use". This innovative disclosure focuses on anti-SSEA4 antibodies and binding fragments, which exhibit high affinity binding to SSEA4 molecules present in various cancer cells like breast cancer, pancreatic cancer, and renal cancer. These antibodies not only induce potent anti-tumor effects but also hold promise for cancer diagnosis and treatment, showcasing his commitment to advancing oncology.

Career Highlights: With a portfolio boasting 12 patents, Chiu-Chen Huang has demonstrated exceptional expertise in the field of biotechnology. His dedication to developing cutting-edge solutions for cancer therapy has earned him recognition as a trailblazer in the industry.

Collaborations: Throughout his illustrious career, Chiu-Chen Huang has collaborated with esteemed professionals such as Rong-Hwa Lin and Chung Nan Chang. His tenure at companies like Abgenomics Cooperatief U.A. and Bioalliance C.V. has provided him with a platform to synergize with like-minded visionaries, fostering a culture of innovation and excellence.

Conclusion: In conclusion, Chiu-Chen Huang's inventive prowess and relentless pursuit of scientific advancement underscore his significant contributions to the field of biomedicine. His innovative patents and collaborations stand as a testament to his dedication to revolutionizing cancer research and improving patient outcomes.

If you have any other requests or need further assistance, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…